These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31039066)

  • 1. A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data.
    Hung A; Gedey R; Groeneweg M; Jay M
    J Manag Care Spec Pharm; 2019 May; 25(5):538-543. PubMed ID: 31039066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.
    Hung A; Mullins CD; Slejko JF; Haines ST; Shaya F; Lugo A
    J Manag Care Spec Pharm; 2019 Mar; 25(3):342-349. PubMed ID: 30816818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study.
    Hung A; Slejko JF; Lugo A; Shaya F; Haines ST; Mullins CD
    J Manag Care Spec Pharm; 2019 Aug; 25(8):913-921. PubMed ID: 31347981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
    Happe LE; Brown JD; Gatwood J; Schneeweiss S; Wang S
    J Manag Care Spec Pharm; 2020 Mar; 26(3):268-274. PubMed ID: 32105168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top Evidentiary Gaps in Managed Care Pharmacy: A Research Agenda.
    Gembarski J; Couto J; Wilson M;
    J Manag Care Spec Pharm; 2020 Apr; 26(4):375-381. PubMed ID: 32130069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed Care Pharmacy Research on Inappropriate Opioid Use Interventions.
    Hertzog LL; McAdam-Marx C; Happe LE
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1199-1202. PubMed ID: 32996387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.
    Greene L; Singh RM; Carden MJ; Pardo CO; Lichtenstein GR
    J Manag Care Spec Pharm; 2019 Aug; 25(8):904-912. PubMed ID: 31007119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between health system specialty pharmacy use and health care costs among national sample of Medicare Advantage beneficiaries.
    Hellems SS; Soni A; Fasching D; Smith BS; McManus DD
    J Manag Care Spec Pharm; 2022 Feb; 28(2):244-254. PubMed ID: 35098745
    [No Abstract]   [Full Text] [Related]  

  • 10. Racial disparities in medication use: imperatives for managed care pharmacy.
    Kogut SJ
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1468-1474. PubMed ID: 33119445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the TRICARE Pharmacy Benefit: A Decade of Change.
    Lugo AM; Allerman AA; Trice SK
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1195-1200. PubMed ID: 31663455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):55-62. PubMed ID: 31880226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
    Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
    J Manag Care Spec Pharm; 2017 Jun; 23(6):613-620. PubMed ID: 28530524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.
    Garry EM; Schneeweiss S; Eapen S; Petruski-Ivleva N; Cheever E; Murk W; Rajan A; Rassen JA; Gambino D; Jang H; Rubin E; Jan S
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1442-1452. PubMed ID: 31778623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.
    Garrison LP; Neumann PJ; Willke RJ
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1185-1192. PubMed ID: 31663458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.
    Yeung K; Suh K; Basu A; Garrison LP; Bansal A; Carlson JJ
    J Manag Care Spec Pharm; 2017 Oct; 23(10):1084-1090. PubMed ID: 28944726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the Budgetary Impact of Payer Utilization Management Strategies: An Adapted Framework Based on Lessons Learned.
    Hung A; Lugo A; Mullins CD
    J Manag Care Spec Pharm; 2019 Aug; 25(8):922-926. PubMed ID: 31347978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A changing order for pharmacy.
    Vogenberg FR; Pisano DJ
    Hosp Pharm; 1995 Nov; 30(11):1002, 1005-6, 1008. PubMed ID: 10152915
    [No Abstract]   [Full Text] [Related]  

  • 19. The three dimensions of managed care pharmacy practice.
    Gouveia WA; Shane R
    Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit.
    Bendicksen L; Kesselheim AS
    J Manag Care Spec Pharm; 2022 Mar; 28(3):354-361. PubMed ID: 35199580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.